| 000 | 01733 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517055856.0 | ||
| 264 | 0 | _c20160801 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a1815-7920 | ||
| 024 | 7 |
_a10.5588/ijtld.14.0935 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aManika, K | |
| 245 | 0 | 0 |
_aRifampicin-moxifloxacin interaction in tuberculosis treatment: a real-life study. _h[electronic resource] |
| 260 |
_bThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _cNov 2015 |
||
| 300 |
_a1383-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntitubercular Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aExtensively Drug-Resistant Tuberculosis _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluoroquinolones _xpharmacokinetics |
| 650 | 0 | 4 | _aGreece |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoniazid _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMoxifloxacin |
| 650 | 0 | 4 | _aOutpatients |
| 650 | 0 | 4 |
_aRifampin _xtherapeutic use |
| 650 | 0 | 4 |
_aTuberculosis, Pulmonary _xdrug therapy |
| 700 | 1 | _aChatzika, K | |
| 700 | 1 | _aPapaioannou, M | |
| 700 | 1 | _aKontou, P | |
| 700 | 1 | _aBoutou, A | |
| 700 | 1 | _aZarogoulidis, K | |
| 700 | 1 | _aKioumis, I | |
| 773 | 0 |
_tThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _gvol. 19 _gno. 11 _gp. 1383-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5588/ijtld.14.0935 _zAvailable from publisher's website |
| 999 |
_c25354714 _d25354714 |
||